Calcium receptor active molecules and method for preparing same
View Patent ↗The invention concerns compounds of general formula (I) wherein: the group X represents a —NR4, —CH═N or —CHR5-NR4-group; the group Y represents an oxygen or sulphur atom or a NR, —CR5, —CHR5-, —CR5=CR6- or —CHR5-CHR6 group provided that when group X represents the —CH═N— or —CHR5-NR4-group, group Y represents an oxygen or a sulphur atom or a Nr, —CR5 or —CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.
1. A compound of the following formula I:
in which:
the group X represents a group
the group Y represents a group
the groups R1 and R5, which may be identical or different, each represent a hydrogen or halogen atom or an alkyl or alkoxy group,
the group R2 represents a hydrogen atom or an alkyl group,
the group R3 represents an aryl group,
and the group R4 represents a hydrogen atom or an alkyl, aryl, aralkyl, alkylsulfonamide, arylsulfonamide or aralkylsulfonamide group,
and its salt with a pharmaceutically acceptable acid, in the form of a racemic mixture or of its optically pure isomer,
and with the exception of compounds, which have the following formulae:
2. The compound of claim 1 , wherein the compound is represented by the following formula III:
and its salt with a pharmaceutically acceptable acid, in the form of a racemic mixture or of its optically pure isomer.
3. The compound of claim 1 , wherein the compound is represented by the following formula IV:
and its salt with a pharmaceutically acceptable acid.
4. A method for preparing the compound of claim 1 , comprising reducing an amide of the following formula V:
in which:
the group X represents a group
the group Y represents a group
the groups R1 and R5, which may be identical or different, each represent a hydrogen or halogen atom or an alkyl or alkoxy group,
the group R2 represents a hydrogen atom or an alkyl group,
the group R3 represents an aryl group,
and the group R4 represents a hydrogen atom or an alkyl, aryl, aralkyl, alkylsulfonamide, arylsulfonamide or aralkylsulfonamide group,
and with the exception of the compounds, which have the following formula:
5. The method of claim 4 , wherein the method further comprises reacting:
(A) an acyl chloride of the following formula VI:
in which:
the group X represents a group
the group Y represents a group
the groups R1 and R5, which may be identical or different, each represent a hydrogen or halogen atom or an alkyl or alkoxy group,
and the group R4 represents a hydrogen atom or an alkyl, aryl, aralkyl, alkylsulfonamide, arylsulfonamide or aralkylsulfonamide group,
with
(B) an amine of the following formula VII:
in which:
the group R2 represents a hydrogen atom or an alkyl group,
and the group R3 represents an aryl group;
so as to obtain the amide of general formula V, wherein the following groups are substituted or unsubstituted: alkyl, alkoxy, aryl, aralkyl, alkylsulfonamide, arylsulfonamide, and aralkylsulfonamide.
6. The method of claim 5 , wherein the method further comprises reacting a carboxylic acid of the following formula VIII:
in which:
the group X represents a group
the group Y represents a group
the groups R1 and R5, which may be identical or different, each represent a hydrogen or halogen atom or an alkyl or alkoxy group,
and the group R4 represents a hydrogen atom or an alkyl, aryl, aralkyl, alkylsulfonamide, arylsulfonamide or aralkylsulfonamide group;
with a thionyl chloride;
so as to obtain acyl chloride of the formula VI, wherein the following groups are substituted or unsubstituted: alkyl, alkoxy, aryl, aralkyl, alkylsulfonamide, arylsulfonamide, and aralkylsulfonamide.
7. A pharmaceutical composition comprising: (A) a compound of the following formula I:
in which:
the group X represents a group
the group Y represents a group
the groups R1 and R5, which may be identical or different, each represent a hydrogen or halogen atom or an alkyl or alkoxy group,
the group R2 represents a hydrogen atom or an alkyl group,
the group R3 represents an aryl group;
and the group R4represents a hydrogen atom or an alkyl, aryl, aralkyl, alkylsulfonamide, arylsulfonamide or aralkylsulfonamide group, wherein the following groups are substituted or unsubstituted: alkyl, alkoxy, aryl, aralkyl, alkylsulfonamide, arylsulfonamide, and aralkylsulfonamide; and
(B) a suitable pharmaceutical carrier.
8. A pharmaceutical composition comprising the compound of claim 2 and a suitable pharmaceutical carrier.
9. A pharmaceutical composition comprising the compound of claim 3 and a suitable pharmaceutical carrier.